4//SEC Filing
CRUTCHFIELD BRADFORD 4
Accession 0001567619-21-022503
CIK 0001770787other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:26 PM ET
Size
10.8 KB
Accession
0001567619-21-022503
Insider Transaction Report
Form 4
CRUTCHFIELD BRADFORD
Chief Commercial Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2021-12-21$1.20/sh+4,688$5,626→ 47,743 total - Exercise/Conversion
Class A Common Stock
2021-12-21$5.04/sh+49,910$251,546→ 97,653 total - Exercise/Conversion
Stock Option (right to buy)
2021-12-21−4,688→ 0 totalExercise: $1.20Exp: 2027-10-18→ Class A Common Stock (4,688 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-12-21−49,910→ 61,757 totalExercise: $5.04Exp: 2028-11-02→ Class A Common Stock (49,910 underlying)
Footnotes (2)
- [F1]This option, originally for 25,000 shares, of which 25,000 shares have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
- [F2]This option, originally for 125,000 shares, of which 63,243 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Documents
Issuer
10x Genomics, Inc.
CIK 0001770787
Entity typeother
Related Parties
1- filerCIK 0001246406
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:26 PM ET
- Size
- 10.8 KB